BioNTech SE
BNTX
$96.47
-$0.26-0.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -633.26M | -381.92M | -812.62M | -717.13M | -500.78M |
| Total Depreciation and Amortization | 424.44M | 328.05M | 323.87M | 320.41M | 228.93M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -213.70M | -488.45M | -405.26M | -700.03M | -349.75M |
| Change in Net Operating Assets | 186.09M | -1.31B | 627.61M | 1.31B | 2.24B |
| Cash from Operations | -236.43M | -1.85B | -266.41M | 210.70M | 1.62B |
| Capital Expenditure | -195.18M | -233.24M | -297.85M | -309.90M | -329.01M |
| Sale of Property, Plant, and Equipment | 5.23M | 2.17M | 1.82M | 1.29M | 545.10K |
| Cash Acquisitions | -82.61M | -82.61M | -82.61M | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.08B | 2.04B | 1.92B | -1.96B | -5.49B |
| Cash from Investing | 803.92M | 1.73B | 1.54B | -2.27B | -5.82B |
| Total Debt Issued | -- | -- | -- | -- | 200.00K |
| Total Debt Repaid | -45.90M | -42.30M | -51.90M | -45.90M | -50.90M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -800.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.84M | -46.08M | -55.64M | -49.58M | -55.69M |
| Foreign Exchange rate Adjustments | -17.14M | 5.47M | -8.53M | 15.80M | -149.20M |
| Miscellaneous Cash Flow Adjustments | -18.45M | 23.37M | 59.47M | 3.45M | 194.09M |
| Net Change in Cash | 481.05M | -139.33M | 1.27B | -2.09B | -4.21B |